WE-REACH

May 14, 2020

WE-REACH Welcomes Teddy Johnson

Photo of Teddy Johnson

We are pleased to welcome Teddy Johnson, P.E., MBA, to the WE-REACH team! Teddy brings 25+ years of medical product development and commercialization experience to his role as Associate Director, Technology Development which is a split role with the Institute of Translational Health Sciences (ITHS). Teddy will work closely with investigators who are taking their early stage…


Federal and State Technology (FAST) Partnership

The U.S. Small Business Administration (SBA) announces the 2020 Federal and State Technology (FAST) Partnership Program.  FAST provides one-year funding to organizations to execute state or regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards. SB-OIIFT-20-001 Federal and State Technology (FAST) Partnership Program Prospective applicants are encouraged…


April 29, 2020

NIBIB Announces Rapid Acceleration of Diagnostics (RADx) Program

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the NIH Point-of-Care…


Event Recap: Responding to COVID-19 A Ground-Zero Perspective from Washington’s Life Science Community

Life Science Washington and the University of Washington through the WE-REACH Biomedical Entrepreneurship Center teamed up to share stories and perspectives from scientists, researchers, and policymakers about the COVID-19 response. If you missed the webinar held April 23 with experts in Seattle talking about where we are with COVID-19 you can watch the video here.   Recaps and…


April 24, 2020

UW Entrepreneurial Law Clinic Resources for COVID-19

The University of Washington Entrepreneurial Law Clinic (a collaborator with WE-REACH) has put together a set of resources to help businesses grappling with COVID-19. In particular, they have several links for R&D funding and grants for Life Sciences businesses. For the full list of Entrepreneurial Law Clinic resources, follow the link.


March 26, 2020

WE-REACH Executive Director Talks Covid-19 with USA Today, Salon, and Geekwire

Dr. Rodney Ho, the Principal Investigator (PI) and Director of the Center for WE-REACH talked with USA Today, Salon, and Geekwire to discuss remdesivir, lopinavir, and hydrocholoroquinine as potential treatments for Covid-19. As part of the center’s focus on providing scientists a bridge to medical impact, WE-REACH has prepared a list of funding opportunities with the NIH. For…


March 20, 2020

Funding for Coronavirus 2019 Treatments, Diagnostics, and Related Solutions

Congress and US federal agencies have responded to the coronavirus threat with funding aimed at fast-tracking promising technologies and products that can help address the needs. Examples of recently funded projects include support of the first high-throughput COVID-19 diagnostic test from Hologic as well as tests from several other companies. Medical Countermeasures BARDA Portal BARDA…


March 16, 2020

Center for AIDS Research Resource Support

Informational Webinar: March 25, 2020 (link) Required Core Consultation Deadline: April 15, 2020 Application Deadline: April 22, 2020 Purpose: To encourage investigators, especially those junior or new to CFAR, to leverage existing CFAR services, data, and/or specimens for short-term, innovative HIV-related pilot projects that are likely to generate sufficient data for subsequent applications for future research funding. Eligibility: A Principal Investigator must:…


March 12, 2020

UW Innovation Highlighted on Italian TV for Treating Covid-19

Dr. Simone Perazzolo, a scientist in the TLC-ART Program, was featured on Italian national TV explaining how an FDA approved protease inhibitor called Lopinavir (Kaletra) may be effective against Covid-19 since requires protease enzymes to replicate. He has highlighted targeted and long-acting drug combinations containing Lopinavir + Tenofovir (HIV and Hepatitis B drugs) currently in…


March 6, 2020

Unitaid to Fund $2MM for Oxygen Therapy Innovations

Unitaid, a partner of the UW TLC-ART Program and a funding arm of the WHO, has announced for innovations in the development of fit-for-purpose oxygen therapy for global health and access. Depending on the scope of the project, the funding range is between USD 500k-2M. The deadline is March 19th, 2020. Please follow the link…


Next page